CA2375673A1 - Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene - Google Patents

Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Download PDF

Info

Publication number
CA2375673A1
CA2375673A1 CA002375673A CA2375673A CA2375673A1 CA 2375673 A1 CA2375673 A1 CA 2375673A1 CA 002375673 A CA002375673 A CA 002375673A CA 2375673 A CA2375673 A CA 2375673A CA 2375673 A1 CA2375673 A1 CA 2375673A1
Authority
CA
Canada
Prior art keywords
hpv39
application
genome
papillomavirus
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002375673A
Other languages
English (en)
Other versions
CA2375673C (fr
Inventor
Gerard Orth
Christoph Volpers
Rolf E. Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2375673A1 publication Critical patent/CA2375673A1/fr
Application granted granted Critical
Publication of CA2375673C publication Critical patent/CA2375673C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne une séquence d'ADN correspondant su génome entier ou partiel de HPV39. Application à la détection in vitro d'une infection due à HPV39 ou à des variantes de celui-ci dans un échantillon biologique.
CA002375673A 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Expired - Lifetime CA2375673C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FRFR90/16044 1990-12-20
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
CA002098819A CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002098819A Division CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Publications (2)

Publication Number Publication Date
CA2375673A1 true CA2375673A1 (fr) 1992-07-09
CA2375673C CA2375673C (fr) 2005-05-17

Family

ID=9403488

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002375673A Expired - Lifetime CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
CA002098819A Expired - Lifetime CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002098819A Expired - Lifetime CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Country Status (10)

Country Link
US (2) US5656423A (fr)
EP (1) EP0563255B1 (fr)
JP (1) JP3859696B2 (fr)
AT (1) ATE112316T1 (fr)
CA (2) CA2375673C (fr)
DE (1) DE69104380T2 (fr)
DK (1) DK0563255T3 (fr)
ES (1) ES2062887T3 (fr)
FR (1) FR2670797A1 (fr)
WO (1) WO1992011369A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
DE69936841D1 (de) * 1998-10-26 2007-09-27 Ventana Med Syst Inc Nachweis des humanen papilloma-virus mit hilfe des papanicolau-tests
WO2000061804A1 (fr) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Agents toxiques et ribozymes specifiques de tissu et specifiques de pathogene
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
WO2004022006A2 (fr) 2002-09-09 2004-03-18 Arbor Vita Corporation Procede de diagnostic du cancer du col de l'uterus
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
JP2004535816A (ja) * 2001-07-20 2004-12-02 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｃｉｎを含むｈｐｖ関連の前癌性増殖および癌性増殖に関する方法および組成物
WO2004002416A2 (fr) * 2002-06-26 2004-01-08 The Penn State Research Foundation Procedes et substances pour traiter des infections au virus du papillome humain
JP4498357B2 (ja) 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
EP1708745B1 (fr) * 2003-12-23 2012-04-18 Arbor Vita Corporation Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation
JP5020825B2 (ja) * 2004-12-08 2012-09-05 ジェン−プローブ・インコーポレーテッド 複数型のヒトパピローマウイルスに由来する核酸の検出
AU2005313858B2 (en) * 2004-12-10 2011-04-07 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
WO2008124091A2 (fr) * 2007-04-05 2008-10-16 Genera Biosystems Limited Compositions et procédés de détection
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
CN102449479B (zh) 2009-05-07 2015-11-25 安科健康公司 鉴别高度或≥cin2用于人乳头瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
WO2011084598A1 (fr) 2010-01-08 2011-07-14 Oncohealth Corporation Immunoessais sur le vph à base de cellule et à haut débit pour diagnostiquer et dépister des cancers associés au vph
JP6153866B2 (ja) * 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (fr) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
FR2670797A1 (fr) 1992-06-26
ATE112316T1 (de) 1994-10-15
ES2062887T3 (es) 1994-12-16
DE69104380T2 (de) 1995-02-09
DE69104380D1 (de) 1994-11-03
US5656423A (en) 1997-08-12
JP3859696B2 (ja) 2006-12-20
US5665535A (en) 1997-09-09
DK0563255T3 (da) 1994-10-24
CA2098819C (fr) 2002-06-18
CA2098819A1 (fr) 1992-06-21
CA2375673C (fr) 2005-05-17
JPH06504672A (ja) 1994-06-02
WO1992011369A1 (fr) 1992-07-09
FR2670797B1 (fr) 1994-08-19
EP0563255A1 (fr) 1993-10-06
EP0563255B1 (fr) 1994-09-28

Similar Documents

Publication Publication Date Title
CA2375673A1 (fr) Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
CA2011878A1 (fr) Regions immunogenes sur la proteine e7 du papillomavirus humain de type 16
CA2158446A1 (fr) Acide nucleique codant pour un precurseur d'antigene de rejet de tumeur
CA2107732A1 (fr) Retrovirus du groupe vih et son utilisation
EP2267132A3 (fr) Fragments proteiques polyepitopiques des proteines e6 et e7 de hpv, leur obtention et leurs utiliations notamment en vaccination
IT1230756B (it) Metodo per la preparazione di polibutadiene a lavorabilita' migliorata.
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
EP0310321A3 (fr) Azaspiranes à activité immunomodulatrice
FR2610631B1 (fr) Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
EP1950221A3 (fr) Séquences génomiques de polypeptides exportés de mycobactéries, vecteurs les comprenant et applications au diagnostic et à la prévention de la tuberculose
ES2021619B3 (es) Conjunto de boca de bloque por embrague.
CA2169603A1 (fr) Retrovirus du groupe vih et son utilisation
CA2055612A1 (fr) Sequences oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in-vitro des infections dues a ces virus
AU7677891A (en) Inhibition of disease associated with immunodeficiency virus infection
EP0240164A3 (fr) Préparation d'azétidinones
FR2604438B1 (fr) Nouveaux conjugues de couplage entre des sequences d'arn ou d'adn et une proteine, leur procede de preparation et leur application biologique
ATE77957T1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
WO1999031269A3 (fr) Nouveau candida albicans kre9 et ses utilisations
EP1047454A4 (fr) Procedes de criblage de composes utiles pour la prevention de l'infection ou de la pathogenicite
FR2659086B1 (fr) Fragments nucleotidiques caracteristiques de fragments d'adn de mycobacteries. leur utilisation comme amorce pour la detection d'une infection due a des mycobacteries.
FR2596874B1 (fr) Montage pour la determination de la presence d'objets, en particulier d'instruments de traitement dentaires, dans des logements ou de l'enlevement de ces objets de ces logements
EP0288198A3 (fr) Production de peptide

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry